methylmalonic acid MMA
Selected indexed studies
- Methylmalonic acid in aging and disease. (Trends Endocrinol Metab, 2024) [PMID:38030482]
- Age-induced accumulation of methylmalonic acid promotes tumour progression. (Nature, 2020) [PMID:32814897]
- Mitochondria-derived methylmalonic acid aggravates ischemia-reperfusion injury by activating reactive oxygen species-dependent ferroptosis. (Cell Commun Signal, 2024) [PMID:38238728]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Testing MMA(100) - the eGFR-adjusted concentration of methylmalonic acid in plasma. (2025) pubmed
- Association between methylmalonic acid and prevalence of depression in US adults: evidence from NHANES 2011-2014. (2025) pubmed
- Vitamin B12-Related Biomarkers. (2024) pubmed
- Methylmalonic acid in aging and disease. (2024) pubmed
- Age-induced accumulation of methylmalonic acid promotes tumour progression. (2020) pubmed
- Mitochondria-derived methylmalonic acid aggravates ischemia-reperfusion injury by activating reactive oxygen species-dependent ferroptosis. (2024) pubmed
- New insights into the pathophysiology of methylmalonic acidemia. (2023) pubmed
- The emerging role of dysregulated propionate metabolism and methylmalonic acid in metabolic disease, aging, and cancer. (2025) pubmed
- Methylmalonic acidemia (MMA). (2005) pubmed
- Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression. (2022) pubmed